Acute heart failure (AHF) – Market Insights, Epidemiology and Market Forecast-2022
Summary of the report:
The Acute heart failure (AHF) – Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, the global AHF market was $188 million in 2015 and expected to grow to $929 million by 2020 with and compound annual growth rate (CAGR) of 17%.
Acute Heart Failure (AHF) is the rapid onset of sign and symptoms of Heart Failure resulting in need and urgent therapy or hospitalization. The AHF primarily includes the symptoms of pulmonary congestion or peripheral perfusion due to cardiac or vascular dysfunction. Based on the recommended guidelines, loop diuretics are the most common treatment for the Acute Heart Failure in patients with dyspnoea caused by pulmonary oedema, more than 90% of patients admitted with AHF receives this drug.
Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Acute heart failure (AHF) market.
• Identifying patient populations in the global Acute heart failure (AHF) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Acute heart failure (AHF) therapeutics in each of the markets covered.
• To understand the future market competition in the global Acute heart failure (AHF) therapeutics market and Insightful review of the key market drivers and barriers.
Get Sample Brochure of the report @ http://www.marketintelreports.com/pdfdownload.php?id=dimfr2016006
Scope of the Report:
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2022.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2022.
• It also provides Acute heart failure (AHF) for United States, EU5 and Japan from 2015 and forecasted Market to 2022.
Order a copy of Acute heart failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016@ http://www.marketintelreports.com/purchase.php?id=dimfr2016006
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.